Related references
Note: Only part of the references are listed.Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer: Results From the TECHNO Trial of the AGO and GBG Study Groups
Michael Untch et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: An update
M Kaufmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer
Tanja Fehm et al.
BREAST CANCER RESEARCH (2006)
Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy
BT Hennessy et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A pooled analysis of bone marrow micrometastasis in breast cancer
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells
T Fehm et al.
CYTOTHERAPY (2005)
The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence
W Janni et al.
CANCER (2005)
Apoptosis of circulating tumor cells in prostate cancer patients
CJ Larson et al.
CYTOMETRY PART A (2004)
Circulating breast cancer cells are frequently apoptotic
G Méhes et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Share Paper
